A startling revelation has emerged from recent data, highlighting a critical issue that affects new mothers in Canada. Nearly half of Canadian new moms battle mental health challenges postpartum, a statistic that demands our attention and action.
Statistics Canada's 2024 Parental Experiences Survey, which surveyed an impressive 11,153 mothers and birthing parents across the country, paints a concerning picture. The survey included a diverse range of individuals, from those who identify as women to transgender and non-binary parents, giving birth between December 2023 and April 2024.
The findings are eye-opening: one in five Canadian mothers and birthing parents reported needing mental health care but not receiving it during pregnancy or the postpartum period. Among those who experienced mental health challenges, an overwhelming 60% said their struggles began after childbirth, with 25% indicating the onset during pregnancy and 15% before pregnancy.
But here's where it gets controversial: 21% of mothers and birthing parents reported that no healthcare provider asked about their emotional well-being during pregnancy or after childbirth.
Lucy Barker, a psychiatrist and early-career scientist at Women's College Hospital, sheds light on this issue. "We know there are many barriers to accessing care," she explains. "Spontaneously bringing up mental health concerns can be challenging for some, so it's crucial that healthcare providers proactively ask and create an open environment."
The survey also revealed disparities among racialized mothers and birthing parents, with 30% indicating they were not asked about their mental or emotional health, compared to 33% of recent immigrants. Additionally, only 29% of racialized mothers received help for their mental health challenges, compared to 41% of non-racialized mothers.
Long wait times and the perception that available care is not helpful were cited as the biggest barriers to accessing mental health care, with 54% and 33% of respondents, respectively, citing these issues.
"Pregnancy and the postpartum period are times of great transition and competing priorities," Barker adds. "For some, it can be difficult to prioritize mental health appointments amidst all the changes."
The survey's findings also "highlight disparities in care," according to Barker. "Ensuring equitable access to care, including routine mental health assessments, is a crucial first step towards providing the necessary support to those in need."
In December 2025, Health Canada approved the drug Zuranolone, a pill designed to treat postpartum depression. This medication targets gamma-aminobutyric acid receptors in the brain, which play a role in mood regulation. It has been recommended for those experiencing moderate to severe postpartum depression, as measured by the level of impairment in daily functioning.
This approval marks a significant step forward in the treatment of postpartum depression, offering a new option for those struggling with this often-overlooked condition.
The data and the approval of Zuranolone serve as a call to action, urging us to prioritize the mental health of new mothers and birthing parents in Canada. With proper support and access to care, we can ensure that these individuals receive the help they need during this vulnerable period of their lives.
What are your thoughts on this issue? Do you think enough is being done to address postpartum mental health in Canada? Share your insights and experiences in the comments below!
